Last updated: October 25, 2026

Application No. 18/854,287

CRYSTALLINE FORM OF LANIFIBRANOR

Non-Final OA

Filed

Oct 04, 2024

Priority

Apr 05, 2022 — EU 22305456.0 +1 more

Examiner

KIFLE, BRUCK

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Inventiva

OA Round

1 (Non-Final)

Interview Optional

— +15.8% interview lift. Examiner has a relatively high allowance rate (79%); +15.8% interview lift. A written response may suffice.

Based on 1742 resolved cases, 2023–2026

Examiner Intelligence

KIFLE, BRUCK View full profile →

Grants 79% — above average

Career Allowance Rate

1381 granted / 1742 resolved

+19.3% vs TC avg

Strong +16% interview lift

Without

With

+15.8%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

44 currently pending

Career history

1788

Total Applications

across all art units

Statute-Specific Performance

§101

5.9%

-34.1% vs TC avg

§103

12.7%

-27.3% vs TC avg

§102

12.2%

-27.8% vs TC avg

§112

53.9%

+13.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1742 resolved cases

Prosecution Timeline

Oct 04, 2024

Application Filed

Jul 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/752,012

Patent 12766146

Salts and Solid Form of a BTK Inhibitor

4y 5m to grant Granted Oct 20, 2026

17/927,094

Patent 12767637

MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF ASSOCIATED DISEASES

3y 11m to grant Granted Oct 20, 2026

18/272,493

Patent 12765555

METHOD FOR CONTROLLING WEEDS

3y 3m to grant Granted Oct 20, 2026

18/692,366

Patent 12766152

GEL COMPOSITION FOR PREVENTION OR TREATMENT OF ATOPIC DERMATITIS

2y 7m to grant Granted Oct 20, 2026

18/040,896

Patent 12760005

BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS

3y 8m to grant Granted Oct 13, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

79%

Grant Probability

95%

With Interview (+15.8%)

1y 10m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1742 resolved cases by this examiner. Grant probability derived from career allowance rate.